Pim - 3, a Proto - Oncogene with Serine / Threonine Kinase Activity, Is Aberrantly Expressed in Human Pancreatic Cancer and Phosphorylates Bad to Block Bad - Mediated Apoptosis in
Human Pancreatic Cancer Cell Lines
During lab testing, the compound «markedly inhibited» the growth of three
human pancreatic cancer cell lines five days after treatment and induced the death of pancreatic cancer cells.
Bacteria (green) inside
human pancreatic cancer cells (AsPC - 1 cells).
This image shows autophagic vesicles containing mutant K - Ras formed in the membrane of
human pancreatic cancer cells after exposure to neratinib.
Not exact matches
«Starting with our
cell model that mimics
human pancreatic cancer progression, we identified released proteins, then tested and validated a subset of these proteins as potential plasma biomarkers of this
cancer,» Zaret said.
While testing the effect of many normal, non-cancerous,
human cells on the sensitivity of
cancer cells to chemotherapy, they found a specific sample of normal
human skin
cells that rendered
pancreatic cancer cells resistant to gemcitabine.
The biomarker panel, enabled by discovery work of first author Jungsun Kim, PhD, a postdoctoral fellow in Zaret's lab, builds on a first - of - its - kind
human -
cell model of
pancreatic cancer progression the lab described in 2013.
In the current study, Dr. Xu and colleagues gave radiation therapy to a mouse model of
human pancreatic cancer to eradicate the bulk tumors, while only the
cancer stem
cells remained in the residual scars.
One of those genes, K - Ras, which was discovered nearly 30 years ago, is mutated in 30 percent of
human tumors, including 90 percent of
pancreatic cancers, 40 percent of colon
cancers, and 20 percent of non-small
cell lung
cancers.
In addition to the afatinib - resistant NSCLC
cells, the researchers tested the neratinib and valproic acid combination on
cell lines derived from
human pancreatic and ovarian
cancers containing K - Ras mutations and N - Ras mutations, respectively.
To overcome this hurdle, researchers genetically engineered
human T
cells to produce a CAR protein that recognizes a glycopeptide found on various
cancer cells but not normal
cells, and then demonstrated its effectiveness in mice with leukemia and
pancreatic cancer.
This image shows an expression of the stem
cell gene Musashi in
human pancreatic cancer.
We chose this model because 1) it more closely recapitulates features of
human pancreatic cancer than do s.c. - implanted tumors, 2) it can be used in immunocompetent mice to permit assessment of immune responses, and 3) the
cells grow in vivo with predictable kinetics (34).
The Carboxyl Tail of Connexin32 Regulates Gap Junction Assembly in
Human Prostate and
Pancreatic Cancer Cells.
I was trying to understand how
pancreatic cancer spreads (metastasises) to lymph nodes, using
human cells and mice to model the process in the lab.
Phytates have been shown to inhibit the growth of
human leukemia
cells, colon
cancer cells, both estrogen receptor - positive and negative breast
cancer cells, voicebox
cancer, cervical
cancer, prostate
cancer, liver tumors,
pancreatic, melanoma, and muscle
cancers.